Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
medworks-media
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Nunzio Pomara, MD: Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
$
30.00
Add to cart
Details
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
$
30.00
Add to cart
Details
Laura Cousino Klein, PhD: Smoking Abstinence Impairs Time Estimation Accuracy in Cigarette Smokers
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Overview of the Safety of Citalopram
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Add to cart
Details
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
$
30.00
Add to cart
Details
Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction
$
30.00
Add to cart
Details
Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
$
30.00
Add to cart
Details
Paul E. Keck, Jr., MD: Definition, Evaluation, and Management of Treatment Refractory Mania
$
30.00
Add to cart
Details
Paul J. Perry, PhD: Therapeutic Drug Monitoring of Antipsychotics
$
30.00
Add to cart
Details
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
$
30.00
Add to cart
Details
Mark S. Bauer, MD: An Evidence-Based Review of Psychosocial Treatments for Bipolar Disorder
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
Add to cart
Details
Clinton D. Kilts, PhD: Imaging the Roles of the Amygdala in Drug Addiction
$
30.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 1 – Full Issue Stacked PDF
$
0.00
Add to cart
Details
Sale!
VOL 3 No. 11 Full Issue – November 2001
$
30.00
$
20.00
Add to cart
Details
Sale!
VOL 4 No. 3 Full Issue – March 2002
$
30.00
$
20.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Differences in Efficacy on Substance Abuse between Risperidone and Clozapine
$
30.00
Add to cart
Details
Catatonia and CPK Elevation in Neurosyphilis
$
30.00
Add to cart
Details
Assessing Rates and Predictors of Tachyphylaxis
$
30.00
Add to cart
Details
Use of Lamotrigine for Bipolar Disorder in Pregnancy and Breastfeeding
$
30.00
Add to cart
Details
Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
$
30.00
Add to cart
Details
Madhukar H. Trivedi – Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
$
30.00
Add to cart
Details
Comparing the Methods Used to Compare Antidepressants
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
George Harrison, MD: Priapism and Quetiapine: A Case Report
$
30.00
Add to cart
Details
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Jennifer L. Donovan, PhD: A Primer on Caffeine Pharmacology and Its Drug Interactions in Clinical Psychopharmacology
$
30.00
Add to cart
Details
K. Ranga R. Krishnan, MD: Informant-Rated Cognitive Symptoms in Normal Aging, Mild Cognitive Impairment, and Dementia
$
30.00
Add to cart
Details
Sanjay J. Mathew, MD: Management of Treatment-Refractory Panic Disorder
$
30.00
Add to cart
Details
Sale!
VOL 4 No. 2 Full Issue – February 2002
$
30.00
$
20.00
Add to cart
Details
Efficacy of Omega-3 Fatty Acids in Mood Disorders
$
30.00
Add to cart
Details
Ross A. Baker – Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
$
30.00
Add to cart
Details
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
Paul E. Holtzheimer III, MD: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression
$
30.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Jose M. Canive, MD: Efficacy of Olanzapine and Risperidone in Schizophrenia: A Randomized Double-Blind Crossover Design
$
30.00
Add to cart
Details
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Previous
1
2
3
4
Next
Close product quick view
×
Title
Page load link
Go to Top